生命科学资讯

RTW's Yarrow to go public in reverse merger with Vyne Therapeutics

Novo Nordisk hit with FDA warning letter over acquired Catalent factory

Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail

AI biotech preview of 2026: Clinic takes center stage

Post-Hoc Live: Endpoints winners and losers list for 2025

Hansa’s enzyme therapy flunks Phase 3 trial in rare kidney disease

GSK wins FDA approval for long-acting asthma drug

Harbour makes $90M upfront deal with Bristol Myers for new antibodies

DBV charts new path to market peanut allergy patch after Phase 3 success

Makary walks back talk of Covid-19 vaccine risk amid internal FDA debate

Verge Genomics' ALS drug fails as biotech shifts to partner model

Mythic Therapeutics shuts down, ends ADC trial as funding dries up

Nektar's immunology drug misses in Phase 2b, execs cite enrollment errors

Pfizer bets big on obesity to offset major patent cliff

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

Calming nerves with a hot wearable

Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board

Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity

RTW startup signs autoimmune antibody pact with China’s GenSci